Latest Comments on ChinaBio Today's Articles

1. mt_tr on Concord Medical IPO Coming This Week: good articles: http://financeopinionss.blogspot.com more »
2. User 521002 on China Biotech Week in Review: Anesiva Forms JV with Fosun Pharma: DEAR SIR we are non governmantal organisation base in niger... more »
3. xksz on Simcere Shuts Down Production in Rabies Vaccine Subsidiary over Quality Control: Simcere said it has suspended the production of all its products,... more »
4. ray b on Pfizer Increases R&D Commitment in China: Viet nam On Nov 26 08:28 PM a. palmer jr. wrote: > It's just a... more »
5. Tom B on China Biotech Week in Review: Two More R&D Centers, One PE Fund, One IPO: And, risking the health of Americans with shady overseas safety... more »
6. a. palmer jr. on China Biotech Week in Review: Two More R&D Centers, One PE Fund, One IPO: In short, Pfizer is closing plants in the United States and... more »
7. balabanovj on China Sky One Nears Approval on Two Diagnostic Tests : This is truly a great company with great vision that has been... more »
8. a. palmer jr. on Pfizer Increases R&D Commitment in China: It's just a matter of time before China gets greedy like we did... more »
9. biomedlives on Pfizer Increases R&D Commitment in China: This story isn't very encouraging for Americans thinking of going... more »
10. a. palmer jr. on Pfizer Increases R&D Commitment in China: I guess now we'll have to worry about lead in our medicine! more »
11. fran grady on Sinovac Adds Vaccine Capacity by Forming JV: Sinovac has prospered in the second half of the year with its... more »
12. BlueOkie on Pfizer Increases R&D Commitment in China: Makes sense! PFE sells more outside the US than in. Of Approx... more »
13. P1llman on Merck Serono to Spend $225 Million on New Beijing R&D Center: The stock ticker MRK is used incorrectly in this story. MRK is... more »
14. huangthomas on Tongjitang Chinese Medicines Reports Another Bad Quarter : This is the time for investors to pause and examine how nascent... more »
15. Jason Tillberg on American Oriental's Q3 Disappoints Again : You can make the case that when stocks go from being good values... more »